Accelerate to discover

Back to filter

Related topics

COVID‐19: Flow cytometry supporting the new challenge for global health

Cytek Biosciences

Apr 9, 2020

Several studies have described the biological and immunological features of the previous coronavirus epidemics, and...

Low-dose imaging in preclinical total-body PET/CT scanner

Bruker Biospin

Apr 8, 2020

Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...

Centrifugation less sample prep. to push forward COVID-19 vaccines development

Curiox

Apr 6, 2020

Sample prep involving centrifugation is risky with potentially infectious samples. Centrifugation of samples can lead...

Loss of Notch1 activity inhibits prostate cancer growth

Spectral Instruments Imaging

Apr 1, 2020

 Prostate cancer remains among the leading causes of cancer-related deaths in men. Loss of NOTCH1 in aggressive...

Apr 9, 2020

xCELLigence system: rapid and sensitive, ideal for infectious viral assays.

Acea Biosciences

Mar 30, 2020

As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...

Genotype-targeted local therapy of glioma

Spectral Instruments Imaging

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

IncuCyte webinar: Organoids, iPSCs, and advanced cell models.

Sartorius

Mar 24, 2020

Researchers are now moving from reductionist, 2D monoculture assay models to more complex 3D cell models, such as...

Apr 9, 2020

Cytek spectral cytometers: 21 color panels with just 2 lasers

Cytek Biosciences

Mar 23, 2020

Until recently, developing multicolor fluorescence-based flow cytometry assays on a two laser system has been limited...

Show all topics (10)

In Vivo Xtreme, preclinical optical and X-ray imaging system

Apr 4, 2016

Xtreme II, the most advanced preclinical Optical/X-ray imaging system, brings a new level of sensitivity, speed and versatility to preclinical imaging. Discover important biological mechanisms in disease, treatments and monitoring using five imaging modalities including bioluminescence, multispectral VIS- NIR fluorescence, unique direct radioisotopic imaging and Cherenkov radiation.

The imaging system allows tumor and stem cell tracking, can provide luminescence imaging of inflammation, offers the optical imaging of PET probes with Cherenkov radiation, allows detection of new probes and biomarker, can track and validate single or multimodal nanoparticles and can discover how genetics, small molecules and therapeutics affect biochemical pathways.

Technical breakthrough
Application
Product news
Video

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey